MTOR and renal cell carcinoma: In this study, we describe the clinical, morphological, immunohistochemical, and molecular characteristics of three additional cases of eosinophilic RCC harboring mTOR gene mutations with histologically documented metastases and, in one case, the clinical response to targeted therapy.